LEADER 01040nam--2200373---450- 001 990003268250203316 005 20090610150219.0 010 $a978-88-15-13108-9 035 $a000326825 035 $aUSA01000326825 035 $a(ALEPH)000326825USA01 035 $a000326825 100 $a20090610d2009----km-y0itay50------ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aCesare e Dio$epotere spirituale e potere secolare in Occidente$fMarco Rizzi 210 $aBologna$cIl mulino$d2009 215 $a221 p.$d22 cm 225 2 $aSaggi$v712 410 0$12001$aSaggi$v712 454 1$12001 461 1$1001-------$12001 606 0 $aChiesa$xRapporti [con lo] Stato$xStoria$2BNCF 676 $a291.177 700 1$aRIZZI,$bMarco$0148019 801 0$aIT$bsalbc$gISBD 912 $a990003268250203316 951 $aII.2. 4246$b216457 L.M.$cII.2.$d00226254 959 $aBK 969 $aUMA 979 $aMARTUCCIEL$b90$c20090610$lUSA01$h1502 996 $aCesare e Dio$9251040 997 $aUNISA LEADER 02600nam0 2200529 i 450 001 VAN0102684 005 20220208102855.976 017 70$2N$a978-1-4614-8301-4 100 $a20150924d2014 |0itac50 ba 101 $aeng 102 $aUS 105 $a|||| ||||| 200 1 $aTargeted cancer treatment in silico$esmall molecule inhibitors and oncolytic viruses$fNatalia L. Komarova, Dominik Wodarz 210 $aNew York$cBirkhäuser ; Springer$d2014 215 $aXV, 227 p.$cill.$d24 cm 410 1$1001VAN0057314$12001 $aModeling and simulation in science, engineering and technology$1210 $aBoston [etc.]$cBirkhäuser 500 1$3VAN0239647$aTargeted cancer treatment in silico$91410618 606 $a60J27$xContinuous-time Markov processes on discrete state spaces [MSC 2020]$3VANC021553$2MF 606 $a37Mxx$xApproximation methods and numerical treatment of dynamical systems [MSC 2020]$3VANC021950$2MF 606 $a92D25$xPopulation dynamics (general) [MSC 2020]$3VANC022805$2MF 606 $a34D20$xStability of solutions to ordinary differential equation [MSC 2020]$3VANC022916$2MF 606 $a92D15$xProblems related to evolution [MSC 2020]$3VANC023324$2MF 606 $a37C75$xStability theory for smooth dynamical systems [MSC 2020]$3VANC029245$2MF 606 $a65Pxx$xNumerical problems in dynamical systems [MSC 2020]$3VANC030747$2MF 606 $a60J85$xApplications of branching processes [MSC 2020]$3VANC030764$2MF 610 $aAntiangiogenic drugs$9KW:K 610 $aCancer Therapy$9KW:K 610 $aCellular automata$9KW:K 610 $aChemotherapy$9KW:K 610 $aOncolytic viruses$9KW:K 610 $aResistance to drugs$9KW:K 610 $aSmall molecule inhibitors$9KW:K 610 $aStochastic modeling$9KW:K 610 $aStomatic evolution$9KW:K 620 $aUS$dNew York$3VANL000011 700 1$aKomarova$bNatalia L.$3VANV080177$0721742 701 1$aWodarz$bDominik$3VANV080178$0721741 712 $aBirkhäuser $3VANV108193$4650 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240614$gRICA 856 4 $uhttp://dx.doi.org/10.1007/978-1-4614-8301-4$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN0102684 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 4429 $e15EB 4429 20191106 996 $aTargeted cancer treatment in silico$91410618 997 $aUNICAMPANIA